NexGel, Inc. (NXGL) - Q3 2024 10-Q Summary
Business Context and Reporting Period
This summary covers NexGel, Inc.'s unaudited financial results for the quarterly period ended September 30, 2024. NexGel manufactures high water content hydrogels for wound care, medical diagnostics, and cosmetics. The company operates through two primary segments: the NexGel segment (manufacturing and branded consumer products) and the CGN JV segment (converting and packaging). Recent strategic shifts include the acquisition of the "Silly George" beauty brand (May 2024) and the "Kenkoderm" skincare line (December 2023), expanding the company beyond its core gel technology into direct-to-consumer retail.
Key Financial Metrics
| Metric | Q3 2024 (3 Months) | Q3 2023 (3 Months) | YTD 2024 (9 Months) | YTD 2023 (9 Months) |
|---|---|---|---|---|
| Net Revenues | $2,940,000 | $1,221,000 | $5,647,000 | $3,007,000 |
| Gross Profit | $1,282,000 | $344,000 | $1,969,000 | $461,000 |
| Gross Margin | 43.6% | 28.2% | 34.9% | 15.3% |
| Net Loss (Attributable to NexGel) | $(693,000) | $(550,000) | $(2,431,000) | $(2,059,000) |
| Net Loss Per Share (Basic) | $(0.11) | $(0.10) | $(0.39) | $(0.36) |
| Cash and Equivalents (End of Period) | $1,059,000 | $3,266,000 | $1,059,000 | $3,266,000 |
| Working Capital | $1,562,000 | $2,503,000 | $1,562,000 | $2,503,000 |
| Total Debt (Notes & Leases) | $1,096,000 | $593,000 | $1,096,000 | $593,000 |
Note: Debt figures include current and non-current portions of notes payable and financing leases. Cash flow from operations was negative $3.0 million for the nine months ended September 30, 2024.
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 140.8% quarter-over-quarter and 87.8% year-over-year. This growth is primarily driven by the "Branded Consumer Products" line, which generated $1.93 million in Q3 2024 compared to $356,000 in Q3 2023. The Silly George acquisition contributed approximately $1.37 million in gross revenue for the quarter.
- Expense Expansion: Selling, General, and Administrative (SG&A) expenses surged 117.9% to $2.07 million in Q3 2024. This was driven by a 460% increase in advertising, marketing, and Amazon fees ($997,000 vs. $178,000) to support new brand launches, as well as increased share-based compensation.
- Liquidity Position: Cash and cash equivalents decreased from $2.7 million at year-end 2023 to $1.06 million at September 30, 2024. This reduction reflects operating losses, capital expenditures ($374,000), and the cash portion of the Silly George acquisition ($400,000), partially offset by equity financing proceeds of $1.95 million.
- Inventory Build: Inventory increased to $1.78 million from $1.32 million at the end of 2023, reflecting stock accumulation for new consumer product lines.
Guidance, Outlook, and Risks
- Going Concern: Management has disclosed substantial doubt about the company's ability to continue as a going concern. The company incurred a net loss of $2.4 million and used $3.0 million in operating cash for the first nine months of 2024. Continued operations depend on successful capital raises and revenue growth.
- Capital Raising: The company recently completed equity offerings in February and August 2024. Additionally, a "November Financing" was announced on November 11, 2024, expecting to raise approximately $2.0 million to fund working capital and general corporate purposes.
- Strategic Focus: Management is prioritizing the expansion of branded consumer products (Silly George, Kenkoderm) and exploring new channels in cosmetics and athletic products. The company also plans to develop proprietary medical devices.
- Risks: Key risks include the inability to raise sufficient capital, intense competition, loss of key customers (one customer represented 10% of YTD revenue), and the integration risks associated with recent acquisitions.
Investor Verification Checklist
- Cash Runway: Verify the closing status and net proceeds of the November 2024 financing to assess immediate liquidity needs given the $1.06 million cash balance.
- Customer Concentration: Review the specific identity and stability of the top customer representing 10% of YTD revenue and the 25% concentration in accounts receivable.
- Acquisition Performance: Monitor the revenue contribution and profitability of the Silly George and Kenkoderm acquisitions against the increased marketing spend required to support them.
- Debt Obligations: Review the terms of the margin line of credit ($345,000 outstanding) and financing leases to understand near-term cash outflow requirements.
- Warrant Liability: Note the $109,000 warrant liability on the balance sheet and its potential impact on future dilution or earnings volatility.